Literature DB >> 33227244

Cross-reinstatement of mitragynine and morphine place preference in rats.

Rima Atria Japarin1, Nurul Hasnida Yusoff1, Zurina Hassan1, Christian P Müller2, Norsyifa Harun3.   

Abstract

Kratom is a medicinal plant that exhibits promising results as an opiate substitute. However, there is little information regarding the abuse profile of its main psychoactive constituent, mitragynine (MG), particularly in relapse to drug abuse. Using the place conditioning procedure as a model of relapse, this study aims to evaluate the ability of MG to induce conditioned place preference (CPP) reinstatement in rats. To evaluate the cross-reinstatement effects, MG and morphine were injected to rats that previously extinguished a morphine- or MG-induced CPP. Following a CPP acquisition induced by either MG (10 and 30 mg/kg, i.p.) or morphine (10 mg/kg, i.p.), rats were subjected to repeated CPP extinction sessions. A low dose priming injection of MG or morphine produced a reinstatement of the previously extinguished CPP. In the second experiment of this study, a priming injection of morphine (1, 3 and 10 mg/kg, i.p.) dose-dependently reinstated an MG-induced CPP. Likewise, a priming injection of MG (3, 10 and 30 mg/kg, i.p.) was able to dose-dependently reinstate a morphine-induced CPP. The present study demonstrates a cross-reinstatement effect between MG and morphine, thereby suggesting a similar interaction in their rewarding motivational properties. The findings from this study also suggesting that a priming exposure to kratom and an opioid may cause relapse for a previously abused drug.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conditioned place preference; Kratom; Mitragynine; Opioid; Rats; Reinstatement

Mesh:

Substances:

Year:  2020        PMID: 33227244     DOI: 10.1016/j.bbr.2020.113021

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.352


  2 in total

Review 1.  Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.

Authors:  Jack E Henningfield; Daniel W Wang; Marilyn A Huestis
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

2.  Kratom pharmacology: Clues from planarians exposed to mitragynine.

Authors:  Sarah Uddin; Sonita Wiah; Tony Kim; Mia N Watson; Tyra Jennings; Scott M Rawls
Journal:  Physiol Behav       Date:  2021-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.